Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Feb;33(2):256-258.
doi: 10.1681/ASN.2021121595. Epub 2022 Jan 20.

Comparing Plasma Donor-Derived Cell-free DNA to Indication Kidney Biopsy Tissue Gene Expression: Toward Understanding the Molecular Equivalents of Non-Invasive Tests

Sunil Kurian  1 , John Friedewald  2
Affiliations
Editorial

Comparing Plasma Donor-Derived Cell-free DNA to Indication Kidney Biopsy Tissue Gene Expression: Toward Understanding the Molecular Equivalents of Non-Invasive Tests

Sunil Kurian et al. J Am Soc Nephrol. 2022 Feb.
No abstract available

Keywords: acute allograft rejection; biomarkers; cell free DNA; gene expression.

PubMed Disclaimer

Comment on

References

    1. Halloran PF, Reeve J, Madill-Thomsen KS, Demko Z, Prewett A, Billings P; Trifecta Investigators : The Trifecta Study: Comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies. J Am Soc Nephrol 33: 387–400, 2022 - PMC - PubMed
    1. Mengel M, Loupy A, Haas M, Roufosse C, Naesens M, Akalin E, et al. : Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation-Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation. Am J Transplant 20: 2305–2317, 2020 - PMC - PubMed
    1. Bloom RD, Bromberg JS, Poggio ED, Bunnapradist S, Langone AJ, Sood P, et al. ; Circulating Donor-Derived Cell-Free DNA in Blood for Diagnosing Active Rejection in Kidney Transplant Recipients (DART) Study Investigators : Cell-free DNA and active rejection in kidney allografts. J Am Soc Nephrol 28: 2221–2232, 2017 - PMC - PubMed
    1. Huang E, Sethi S, Peng A, Najjar R, Mirocha J, Haas M, et al. : Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients. Am J Transplant 19: 1663–1670, 2019 - PubMed
    1. Park S, Guo K, Heilman RL, Poggio ED, Taber DJ, Marsh CL, et al. : Combining blood gene expression and cellfree DNA to diagnose subclinical rejection in kidney transplant recipients. Clin J Am Soc Nephrol 16: 1539–1551, 2021 - PMC - PubMed

Substances